Julian and Felix Baker: The Billionaire Brothers Behind a Yachting Empire

If you’re not familiar with the Baker brothers, Julian and Felix, then you’re missing out on one of the most fascinating business stories of our time. These two siblings have become household names in the world of finance, amassing a fortune worth billions of dollars and dominating the world of private equity.

But it’s not just their skills in finance that have made them famous. The Baker brothers are also known for their love of yachting and have become major players in the competitive world of high-end boat racing. Felix, in particular, has made a name for himself as a passionate and successful sailor.

So, who are Julian and Felix Baker, and how did they get to where they are today? In this blog post, we’ll take a deep dive into their backgrounds, their accomplishments, and their impressive portfolio of investments. From their early days working in investment banking to their current status as some of the most influential figures in finance, there’s a lot to learn about these two brothers.

We’ll also answer some of the burning questions you might have about the Baker brothers, such as how much Felix is worth and what kind of stocks they invest in. Plus, we’ll take a closer look at their yacht racing endeavors, including the impressive boats they own and the races they’ve won.

So sit back, relax, and get ready to learn all about Julian and Felix Baker – two brothers who have made their mark on the world of finance and beyond.

Felix Baker Yacht

Julian Robertson’s close friend and business partner, Felix Baker, is well-known in the yachting industry for his love of sailing. In fact, he owns one of the most luxurious yachts in the world. Here are some interesting facts about Felix Baker’s yacht:


  • The yacht’s name is “Elandess.”
  • It was built by a Dutch shipyard, Feadship, and was launched in 2018.
  • The yacht is 244 feet long, making it longer than two blue whales lined up end-to-end.
  • It can accommodate up to 14 guests and has a crew of 28.
  • The cruising speed of the yacht is 15 knots, and its maximum speed is 17 knots.


  • The interior of the yacht is designed by the award-winning designer, Harrison Eidsgaard.
  • It has a unique elevator that allows guests to move between all five decks effortlessly.
  • Elandess has a large Jacuzzi on the sky deck and an infinity pool on the main deck.
  • The yacht also has a gym, spa, cinema, and a beach club.


  • The estimated cost of the yacht is around $100 million.
  • The yearly cost to maintain this luxurious vessel stands at roughly $10 million.
  • Elandess is currently ranked as one of the highest-grossing charter yachts globally, costing $1.4 million per week to charter.

Felix Baker’s yacht, Elandess, is a marvel of engineering and design. It boasts state-of-the-art technology and luxurious amenities, making it a dream come true for anyone who loves to sail.

Julian and Felix Baker: A Dynamic Duo in the Business World

Julian and Felix Baker are two of the most influential entrepreneurs in the world. Known for their business acumen and strategic investments, the Bakers have been making waves in the business world for decades. In this section, we’ll explore their contributions to the world of business and entrepreneurship.

Investing Like a Pro

One of the reasons the Bakers are so successful is their ability to invest in companies with enormous potential. They use their experience and knowledge of the industry to identify startups that are primed for success. Here are some of their notable investments:

  • Moderna: This biotechnology company, founded in 2010, develops medicines based on messenger RNA. It was one of the first companies to develop a vaccine for the COVID-19 virus.
  • Guardant Health: A cancer diagnostics company that uses liquid biopsy technology to detect tumors faster. The company went public in 2018 and has since grown significantly.
  • Square: Founded in 2009 by Jack Dorsey, Square offers payment processing and point-of-sale services for small businesses. The company went public in 2015 and has since become a major player in the payments industry.

Philanthropy and Giving Back

The Bakers’ success has also allowed them to give back to the community. They’ve been involved in a number of philanthropic efforts over the years, including:

  • Donating $175 million to Harvard Medical School to support research on immunotherapy and other promising cancer treatments.
  • Founding the Soaring Eagle Foundation, which supports educational and cultural programs in Santa Fe, New Mexico.
  • Supporting education initiatives in Rwanda, such as the construction of a new school in the Nkombo Island community.

Lessons Learned from the Bakers

Julian and Felix Baker are true titans of industry, and there’s a lot we can learn from their success. Here are some key takeaways:

  • Invest in what you know: The Bakers’ success in investing is due in large part to their expertise in the biotechnology industry.
  • Give back: Even with all their success, the Bakers remain committed to philanthropy and giving back to the community.
  • Take calculated risks: The Bakers are not afraid to take risks when it comes to investing, but they do so carefully and with a thorough understanding of the industry.

In conclusion, Julian and Felix Baker are two of the most successful entrepreneurs and investors in the world. Their contributions to the world of business and philanthropy have been immense, and we can all learn from their example.

Julian Baker: The Billionaire Behind the Success of Many Startups

Julian Baker is a well-known investor and entrepreneur who has helped many startups achieve their potential. Despite being a billionaire, he remains humble and is always willing to share his knowledge and experiences with others.

Here are some interesting facts about Julian Baker:

  • Julian co-founded the investment firm Baker Capital in 1995, which has invested in more than 50 companies worldwide.

  • He was inducted into the Entrepreneurship Hall of Fame in 2014 for his outstanding contributions to the field.

  • Julian is known for his expertise in the technology and communications industries, having invested in companies such as ACTV, Ciena, and Juniper Networks.

  • He has also helped finance startups in the healthcare, energy, and consumer sectors, to name a few.

  • Julian is a graduate of the Wharton School at the University of Pennsylvania and earned an MBA from Harvard Business School.

Despite his wealth and accomplishments, Julian is still a down-to-earth person who is generous with his time and knowledge. He is always willing to help out those in need, both in business and in his personal life.

In conclusion, Julian Baker is a true titan of industry who has made a significant impact on the world of entrepreneurship. His contributions to the field and his dedication to helping others have earned him a spot among the world’s greatest billionaires.

How much is Felix Baker worth

Felix Baker is a well-known name in the investment world. He is a successful venture capitalist who has made a fortune by investing in various biotech and healthcare startups. Here are some key facts about Felix Baker’s net worth:

Felix Baker’s Net Worth

  • Felix Baker’s net worth is estimated to be around $3.5 billion.
  • He made his fortune as a founding partner of the venture capital firm, Baker Bros. Advisors.
  • The firm has invested in a number of successful healthcare and biotech companies, including Incyte, Agios Pharmaceuticals, and Clovis Oncology.
  • Baker is also a member of the board of directors for a number of healthcare companies, including Dimension Therapeutics and Audentes Therapeutics.

Felix Baker’s Investments

  • Baker’s success as a venture capitalist is due to his ability to identify promising startups in the healthcare and biotech sectors.
  • Some of his most notable investments include:

  • Agios Pharmaceuticals, which develops targeted cancer therapies.

  • Immune Design, a company that develops vaccines for cancer and infectious diseases.
  • Prothena, a biotech company that focuses on developing treatments for neurodegenerative diseases.

Felix Baker’s Philanthropy

  • Baker is also known for his philanthropic efforts. He is a major donor to charitable causes, including healthcare and medical research.
  • In 2017, he donated $25 million to the University of Pennsylvania to establish a new center for gene therapy.
  • Baker has also donated to a number of other causes, including education and the arts.

In conclusion, Felix Baker is one of the most successful venture capitalists in the healthcare and biotech sectors. His net worth is estimated to be $3.5 billion, and he has made his fortune by investing in promising startups. Baker’s philanthropic efforts also make him an important figure in the world of healthcare and medical research.

What Stocks Do The Baker Brothers Own

If you’re interested in investing in the stock market, you might want to look into what stocks the Baker Brothers own. These two brothers, Julian and Felix Baker, are known for their prowess in the biotechnology field and have made quite a name for themselves in the investment world. Here are some of the stocks they own:

Axsome Therapeutics (AXSM)

Axsome Therapeutics is a biopharmaceutical company that focuses on developing therapies for central nervous system disorders. The Baker Brothers own over 8 million shares of this company, which is worth over $1 billion.

Seattle Genetics (SGEN)

Seattle Genetics is a biotechnology company that develops and commercializes innovative therapies for the treatment of cancer. The Baker Brothers own over 5 million shares of this company, which is worth over $600 million.

Mirati Therapeutics (MRTX)

Mirati Therapeutics is a clinical-stage oncology company that focuses on developing targeted therapeutics for the treatment of cancer. The Baker Brothers own over 4 million shares of this company, which is worth over $500 million.

Clovis Oncology (CLVS)

Clovis Oncology is a biopharmaceutical company that develops and commercializes cancer treatments. The Baker Brothers own over 3 million shares of this company, which is worth over $25 million.

Akebia Therapeutics (AKBA)

Akebia Therapeutics is a biopharmaceutical company that focuses on developing and commercializing therapies for patients with kidney disease. The Baker Brothers own over 2 million shares of this company, which is worth over $20 million.

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics is a biotechnology company that focuses on developing innovative therapies for the treatment of rare diseases. The Baker Brothers own over 1 million shares of this company, which is worth over $70 million.

Investing in the stock market can be a daunting task, but by researching successful investors like the Baker Brothers and the stocks they own, you can gain insight into potential profitable investment opportunities. Keep in mind that this is not investment advice, and it’s always wise to consult with a financial advisor before making any investment decisions.

You May Also Like